Alliance Co-Leads Letter to DEA Urging Action on Telehealth Rule Crucial for Mental Health, Substance Use Disorders

FOR IMMEDIATE RELEASE                                                      Stakeholders Send Letter to DEA Urging Action on Telehealth Rule Crucial for Mental Health, Substance Use Disorders WASHINGTON, DC, APRIL 2, 2024 – The Alliance for Connected Care, American Telemedicine Association, ATA Action, the Consumer Technology Association, and the Healthcare Information and Management Systems Society, co-leading the effort, submitted a letter [...]

2024-04-12T17:00:23-04:00April 2nd, 2024|

Alliance Highlights the Importance of a Special Registration to Allow Continuity of Care for Patients

The Alliance for Connected Care appreciated the opportunity to testify for the Drug Enforcement Administration's (DEA) listening session on prescribing controlled substances via telemedicine on September 12, 2023. We appreciate the DEA’s quick response during the COVID-19 public health emergency (PHE) to allow prescribing via telemedicine. This was also a hugely meaningful expansion of access [...]

2024-04-12T17:02:31-04:00September 12th, 2023|

Concerns Align on the DEA Telemedicine Rule

Over 35,000 Americans provided comments on the Drug Enforcement Administration's (DEA) proposed rule, "Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation." In comment letters responding to the DEA's proposed rule, hundreds of key stakeholders highlighted the need for a special registration for telemedicine and [...]

2024-04-12T17:02:20-04:00April 7th, 2023|

Alliance Submits Comments to the DEA Proposed Rule on Prescribing Controlled Substance via Telemedicine

The Alliance for Connected Care submitted comments in response to the request for information from the Drug Enforcement Administration's (DEA) proposed rule, Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation.  The Alliance highlights its concerns that the rule does not satisfy multiple congressional [...]

2024-04-12T17:02:12-04:00March 29th, 2023|

Alliance and Others Send Letter to DEA to Advance Proposed Rules on the Special Registration Telemedicine

Alliance and Others Send Letter to DEA to Advance Proposed Rules on the Special Registration Telemedicine The Alliance for Connected Care and more than 300 participants sent a letter urging the DEA to advance the proposed rules on the Special Registration for Telemedicine under the Ryan Haight Act to the Office of Management and Budget (OMB). [...]

2024-04-12T17:01:53-04:00November 11th, 2022|

Alliance Letter to ONDCP Special Telemedicine Registration

The Alliance for Connected Care sent the attached letter to the White House Office of National Drug Control Policy (ONDCP) applauding their inclusion of the telemedicine special registration for the prescribing of controlled substances this year as part of the Biden Administration’s First-Year Drug Policy Priorities. The Biden Administration outlined its drug policy priorities for [...]

2024-04-12T17:01:46-04:00April 12th, 2021|

Alliance Joins Letter to Hill in Support of Temporary Extension of DEA Waiver in COVID Relief Package

The $908 Billion Bipartisan Emergency COVID Relief Act of 2020 – While its outcome remains very much in doubt, the $908 Billion bipartisan compromise proposal put forward in the Senate includes a provision to temporarily extend the DEA waiver of the in-person requirement through the end of 2021. We urge Congress to extend the Drug [...]

2024-04-12T17:01:27-04:00December 15th, 2020|
Go to Top